龍蟒佰利(002601.SZ):龍佰鈦業擬出資4億元成立甘肅佰利聯化學
格隆匯5月28日丨龍蟒佰利(002601.SZ)公佈,根據公司經營及戰略發展的需要,為進一步提高公司市場佔有率,加強公司競爭力,公司全資子公司龍佰四川鈦業有限公司(“龍佰鈦業”)擬出資4億元人民幣在甘肅省金昌市成立甘肅佰利聯化學有限公司(暫定名,最終名稱以工商行政管理部門核准登記為準)。
上述公司的設立是根據公司經營及戰略發展的需要,進一步提高公司市場佔有率,加強公司競爭力,提高盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.